Cell Therapy Technologies Market With Additive Manufacturing, Demand, Domestic Projects, Core Technology, Price, Policy And Report To 2032|Thermo Fisher Scientific, Merck, MaxCyte, Lonza Group, Sartorius

Spread the love

The Cell Therapy Technologies Global Market Report 2023 by The Business Research Company, provides cell therapy technologies market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Cell Therapy Technologies Market:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

According to The Business Research Company’s Cell Therapy Technologies Global Market Report 2023, the global cell therapy technologies market size grew from $3.53 billion in 2022 to $4.24 billion in 2023 at a compound annual growth rate (CAGR) of 20.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global cell therapy technologies is expected to grow to $7.39 billion in 2027 at a CAGR of 14.9%.

Increasing investments by the government in cell-based research contributed to the growth of the global cell therapy technologies market. Governments are increasingly investing in research activities for developing therapies for diseases such as cancer, cardiovascular disease (CVD), and others.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

The cell therapy technologies market is segmented:

1) By Product: Consumables, Equipment, Systems & Software

2) By Cell Type: T-cells, Stem Cells, Other Cells

3) By Process: Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control

4) By End User: Life Science Companies, Research Institutes

Strategic collaborations and partnerships between the industry players are gaining popularity in the cell therapy technologies market. Major companies are collaborating and partnering with other companies to develop new technologies in cell therapy areas for the treatment of a variety of diseases. For instance, in August 2020, IsoPlexis Corporation, USA-based, collaborated with Lonza, a Switzerland-based chemicals and biotechnology company, to enable the next generation of precision cell therapy manufacturing. In another instance, in July 2020, Hitachi, Ltd., a Japan-based provider of a broad range of solutions including automated cell culture technologies to pharmaceutical companies in the area of cell therapy and regenerative medicine industry, collaborated with ThinkCyte, Inc., a Japan-based biotechnology company to focus on developing artificial intelligence (AI)-driven cell analysis and sorting system.

The cell therapy technologies market report table of contents includes: